. 2018 Sep 7;7(11):1142–1149. doi: 10.1530/EC-18-0268
This work is licensed under a Table 2.
Patient and tumor characteristics of incidental findings and suspected findings.
| Incidental findings (n = 148) | Suspected findings (n = 378) | P value | |
|---|---|---|---|
| Sex, male/female | 71/77 | 182/196 | 0.242 |
| Age (years) (average (medium)) | 47.8 (49) | 44.4 (45) | 0.246 |
| BMI (kg/m2) (average (STDEV)) | 21.2 (3.2) | 22.0 (2.7) | 0.213 |
| Tumor side, unilateral/bilateral | 138/10 | 349/29 | 0.721 |
| Tumor diameter (average (STDEV)) | 5.3 (2.8) | 5.4 (2.6) | 0.822 |
| Documented with hypertension (%) | 48 (32.4) | 289 (76.5) | <0.001 |
| Preoperative normetanephrine in plasma (ng/L) (average (STDEV)) | 4363 (11,454) | 5076 (13,402) | 0.745 |
| Preoperative metanephrine in plasma (ng/L) (average (STDEV)) | 280 (362) | 427 (981) | 0.319 |
| Preoperative normetanephrine in unrine (μg/24 h) (average (STDEV)) | 583 (817) | 769 (1030) | 0.728 |
| Preoperative metanephrine in urine (μg/24 h) (average (STDEV)) | 87 (216) | 141 (218) | 0.548 |
| Non-functioning pheochromocytoma (%) | 87 (58.8) | 108 (28.6) | <0.001 |
| Multiple endocrine neoplasia II (%) | 2 (1.5) | 33 (8.7) | <0.001 |